Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-29

Clinical Trial Update: Ramelteon for Insomnia Comorbid With Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial of ramelteon for insomnia in patients with comorbid asthma was terminated, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramelteon (ramelteon)

Snippet

Sponsor: Northwestern University | Conditions: Insomnia, Asthma | Phase 3 | Status: TERMINATED | Results posted: 2012-06-29